Last updated: 4 months ago
NLS Pharmaceutics Ltd. Reports Merger Plans in Form 6-K Filing
On Jan 16, 2025, NLS Pharmaceutics Ltd. announced a special meeting for a merger with Kadimastem. This Form 6-K highlights key corporate developments and regulatory compliance.